As on April 01, 2021, BioXcel Therapeutics Inc. (NASDAQ: BTAI) started slowly as it slid -12.81% to $37.63. During the day, the stock rose to $40.77 and sunk to $36.50 before settling in for the price of $43.16 at the close. Taking a more long-term approach, BTAI posted a 52-week range of $16.00-$71.50.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -87.20%. This publicly-traded company’s shares outstanding now amounts to $24.39 million, simultaneously with a float of $14.67 million. The organization now has a market capitalization sitting at $1.06 billion. At the time of writing, stock’s 50-day Moving Average stood at $49.83, while the 200-day Moving Average is $48.88.
BioXcel Therapeutics Inc. (BTAI) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. BioXcel Therapeutics Inc.’s current insider ownership accounts for 0.20%, in contrast to 55.30% institutional ownership. According to the most recent insider trade that took place on Mar 15, this organization’s Chief Scientific Officer sold 15,000 shares at the rate of 48.50, making the entire transaction reach 727,573 in total value, affecting insider ownership by 58,397. Preceding that transaction, on Feb 17, Company’s Chief Medical Officer sold 25,000 for 55.58, making the whole transaction’s value amount to 1,389,459. This particular insider is now the holder of 0 in total.
BioXcel Therapeutics Inc. (BTAI) Earnings and Revenue Records
If we go through the results of last quarter, which was made public on 12/30/2020, the company posted -$0.87 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$0.96) by $0.09. This company achieved a return on equity of -70.35. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.03 per share during the current fiscal year.
BioXcel Therapeutics Inc.’s EPS decrease for this current 12-month fiscal period is -87.20% and is forecasted to reach -3.25 in the upcoming year.
BioXcel Therapeutics Inc. (NASDAQ: BTAI) Trading Performance Indicators
Let’s observe the current performance indicators for BioXcel Therapeutics Inc. (BTAI). It’s Quick Ratio in the last reported quarter now stands at 18.30. The Stock has managed to achieve an average true range (ATR) of 3.85.
In the same vein, BTAI’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.78, a figure that is expected to reach -0.94 in the next quarter, and analysts are predicting that it will be -3.25 at the market close of one year from today.
Technical Analysis of BioXcel Therapeutics Inc. (BTAI)
Through scrutinizing the latest numbers posted by the [BioXcel Therapeutics Inc., BTAI], it can be observed that its last 5-days Average volume of 0.76 million was better the volume of 0.6 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 31.72% While, its Average True Range was 3.63.
Raw Stochastic average of BioXcel Therapeutics Inc. (BTAI) in the period of the previous 100 days is set at 3.62%, which indicates a major fall in contrast to 8.51% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 89.91% that was higher than 83.39% volatility it exhibited in the past 100-days period.